financetom
Business
financetom
/
Business
/
RTX Unusual Options Activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RTX Unusual Options Activity
May 10, 2024 9:43 AM

Whales with a lot of money to spend have taken a noticeably bearish stance on RTX.

Looking at options history for RTX we detected 10 trades.

If we consider the specifics of each trade, it is accurate to state that 30% of the investors opened trades with bullish expectations and 60% with bearish.

From the overall spotted trades, 5 are puts, for a total amount of $311,408 and 5, calls, for a total amount of $199,253.

Expected Price Movements

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $110.0 for RTX during the past quarter.

Analyzing Volume & Open Interest

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for RTX's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of RTX's whale trades within a strike price range from $100.0 to $110.0 in the last 30 days.

RTX 30-Day Option Volume & Interest Snapshot

Noteworthy Options Activity:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
RTX PUT SWEEP BEARISH 09/20/24 $6.35 $6.25 $6.35 $110.00 $90.8K 14 10
RTX PUT SWEEP BULLISH 07/19/24 $2.19 $2.03 $2.15 $105.00 $77.8K 1.3K 503
RTX PUT SWEEP BEARISH 06/20/25 $9.95 $9.9 $9.9 $110.00 $67.2K 12 69
RTX CALL TRADE BULLISH 05/31/24 $4.05 $4.05 $4.05 $102.00 $50.6K 1.1K 315
RTX CALL SWEEP BEARISH 05/31/24 $4.25 $4.1 $4.15 $102.00 $50.2K 1.1K 561

About RTX

RTX is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufacturers and to the defense market. The company operates in three segments: Collins Aerospace, a diversified aerospace supplier; Pratt & Whitney, an aircraft engine manufacturer; and Raytheon, a defense prime contractor providing a mix of missiles, missile defense systems, sensors, hardware, and communications technology to the military.

Having examined the options trading patterns of RTX, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

RTX's Current Market Status

With a volume of 1,804,942, the price of RTX is up 0.23% at $105.98.

RSI indicators hint that the underlying stock may be overbought.

Next earnings are expected to be released in 74 days.

What Analysts Are Saying About RTX

A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $108.8.

Maintaining their stance, an analyst from Susquehanna continues to hold a Positive rating for RTX, targeting a price of $119.

Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for RTX, targeting a price of $100.

An analyst from B of A Securities persists with their Neutral rating on RTX, maintaining a target price of $110.

An analyst from Citigroup has decided to maintain their Neutral rating on RTX, which currently sits at a price target of $110.

An analyst from UBS persists with their Neutral rating on RTX, maintaining a target price of $105.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for RTX with Benzinga Pro for real-time alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Johnson & Johnson To Obtain Rights To A Clinical-Stage Bispecific Antibody To Address Distinct Patient Needs In Atopic Dermatitis
BRIEF-Johnson & Johnson To Obtain Rights To A Clinical-Stage Bispecific Antibody To Address Distinct Patient Needs In Atopic Dermatitis
May 28, 2024
May 28 (Reuters) - Johnson & Johnson: * JOHNSON & JOHNSON TO OBTAIN RIGHTS TO A CLINICAL-STAGE BISPECIFIC ANTIBODY TO ADDRESS DISTINCT PATIENT NEEDS IN ATOPIC DERMATITIS * J&J - PROPOSED DEAL FOR ALL-CASH TRANSACTION OF APPROXIMATELY $1.25 BILLION * J&J - PROPOSED DEAL FOR ALL-CASH TRANSACTION OF APPROXIMATELY $1.25 BILLION * J&J: ENTERS AGREEMENT WITH NUMAB THERAPEUTICS TO ACQUIRE...
Novelis Files to Offer 45 Million Common Shares in IPO
Novelis Files to Offer 45 Million Common Shares in IPO
May 28, 2024
07:38 AM EDT, 05/28/2024 (MT Newswires) -- Novelis filed on May 28 to offer 45 million common shares in its initial public offering with an estimated price per share of between $18 to $21. ...
BRIEF-Transdigm Announces Acquisition Of Raptor Scientific
BRIEF-Transdigm Announces Acquisition Of Raptor Scientific
May 28, 2024
May 28 (Reuters) - TransDigm Group Inc ( TDG ): * TRANSDIGM ANNOUNCES ACQUISITION OF RAPTOR SCIENTIFIC Source text for Eikon: Further company coverage: ...
BRIEF-Numab Therapeutics Announces Johnson & Johnson To Acquire Its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights To Nm26, A Bi-Specific Antibody For The Treatment Of Atopic Derm
BRIEF-Numab Therapeutics Announces Johnson & Johnson To Acquire Its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights To Nm26, A Bi-Specific Antibody For The Treatment Of Atopic Derm
May 28, 2024
May 28 (Reuters) - Johnson & Johnson ( JNJ ): * NUMAB THERAPEUTICS ANNOUNCES JOHNSON & JOHNSON TO ACQUIRE ITS WHOLLY-OWNED SUBSIDIARY YELLOW JERSEY THERAPEUTICS INCLUDING RIGHTS TO NM26, A BI-SPECIFIC ANTIBODY FOR THE TREATMENT OF ATOPIC DERMATITIS Source text for Eikon: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved